Clin2
NCT03849443Possibly a fitRecruiting

Testing tranexamic acid to reduce bleeding after spine fusion

Open Posterior Thoracolumbar Spinal Fusion Procedure

Treatments studied

Part of Blood & lymphatic, Bones, joints & muscles clinical trials.

This trial studies whether a single dose or multiple doses of tranexamic acid (TXA) can reduce the chance you need a blood transfusion after spine fusion surgery. It also compares two different ways TXA may be given (by mouth and through a vein) to see which approach works best and is safe.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
604 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You are scheduled for an open posterior thoracolumbar spine fusion operation
  • You do NOT have an allergy to tranexamic acid (TXA)
  • You must be willing to accept blood products if needed
  • You have NOT taken blood thinners (anticoagulants) within 5 days before surgery
  • You are not pregnant or breastfeeding

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02314988Recruiting· Phase 2/Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.

San Francisco, California
NCT03553186Recruiting· Phase 3
Tranexamic acid to reduce bleeding in spine surgery

This Phase 3 trial tests whether tranexamic acid can reduce bleeding during major spine fusion surgery for adults with scoliosis or spine degeneration. It may help lessen blood loss and the need for transfusions, while monitoring safety.

New York, New York
NCT04312880Enrolling by invitation· Phase 4
Tranexamic acid during elective back surgery to reduce bleeding

This trial studies whether giving tranexamic acid (a medicine that helps reduce bleeding) during planned lower-back decompression surgery can lower blood loss or related complications. It compares patients who receive the infusion during surgery to those who meet study procedures and safety requirements.

Albany, New York
NCT06427850Not yet recruiting
Tranexamic acid for less bleeding during spine surgery

This trial tests if a medicine applied directly to the spine during a common type of back surgery (MI-TLIF) can reduce the amount of fluid that needs to be drained afterward. Tranexamic acid (TXA) helps blood clot, so using it this way may help you heal with less drainage.

NCT07494032Not yet recruiting
Extended Oral Tranexamic Acid After Knee Replacement

This trial tests if taking tranexamic acid (TXA) pills for a week after knee replacement surgery helps reduce bleeding and the need for blood transfusions. You may qualify if you are having a planned first-time knee replacement with spinal anesthesia and are already scheduled for standard care.

New York, New York
NCT06023212Recruiting· Phase 1/Phase 2
Tranexamic acid to prevent bleeding in spine surgery for lung cancer

This trial tests if a medicine called tranexamic acid can help reduce bleeding during surgery for lung cancer that has spread to the spine. It may be an option if you have a single tumor in your spine and are having separation surgery.

Hangzhou, Zhejiang

Hear when a new Open Posterior Thoracolumbar Spinal Fusion Procedure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.